Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage

Stroke

Volumn 40, Issue 2, 2009, Pages 632-639

  James, Michael L ^a   Sullivan, Patrick M ^a   Lascola, Christopher D ^a   Vitek, Michael P ^a,b   Laskowitz, Daniel T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Optimal Screening Vehicles Division   (United States)

Author keywords

Apolipoprotein e; Gene therapy; Inflammation; Intracerebral hemorrhage; Mouse

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E MIMETIC PEPTIDE; BACTERIAL ENZYME; COG 1410; COLLAGENASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; CLOSTRIDIOPEPTIDASE A; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN WATER; CLOSTRIDIUM; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENOTYPE; HOMOZYGOSITY; LATENT PERIOD; MOUSE; NEUROLOGIC EXAMINATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROTAROD TEST; TREATMENT OUTCOME; UPREGULATION; WATER CONTENT; WILD TYPE; ANIMAL; BODY EQUILIBRIUM; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; MICROINJECTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOGENETICS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOTACTIC PROCEDURE; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS E; BASAL GANGLIA; CEREBRAL HEMORRHAGE; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MICROBIAL COLLAGENASE; MICROINJECTIONS; NERVOUS SYSTEM DISEASES; PEPTIDES; PHARMACOGENETICS; POLYMORPHISM, GENETIC; POSTURAL BALANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 60549101667     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.530402     Document Type: Article

References (32)

1. Laskowitz DT, Vitek MP. Apolipoprotein e and neurological disease:Therapeutic potential and pharmacogenomic interactions. Pharmacog-enomics. 2007;8:959-969.
2. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 1995;346:575.
3. Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P, Kissela B, Pancioli A, Jauch E, Kleindorfer D, Flaherty M, Schneider A, Khatri P, Sauerbeck L, Khoury J, Deka R, Broderick J. Association of apolipoprotein e4 and haplotypes of the apolipoprotein e gene with lobar intracerebral hemorrhage. Stroke. 2005;36:1874-1879.
4. Tzourio C, Arima H, Harrap S, Anderson C, Godin O, Woodward M, Neal B, Bousser MG, Chalmers J, Cambien F, MacMahon S. ApoE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology. 2008;70:1322-1328.
5. Duan RS, Chen Z, Dou YC, Concha Quezada H, Nennesmo I, Adem A, Winblad B, Zhu J. Apolipoprotein e deficiency increased microglial activation/ccr3 expression and hippocampal damage in kainic acid exposed mice. Exp Neurol. 2006;202:373-380.
6. Lynch JR, Wang H, Mace B, Leinenweber S, Warner DS, Bennett ER, Vitek MP, McKenna S, Laskowitz DT. A novel therapeutic derived from apolipoprotein e reduces brain inflammation and improves outcome after closed head injury. Exp Neurol. 2005;192:109-116.
7. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT. ApoE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem. 2003;278:48529-48533.
8. Xue M, Del Bigio MR. Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats. J Stroke Cerebrovasc Dis. 2003;12:152-159.
9. McCarron MO, Hoffmann KL, DeLong DM, Gray L, Saunders AM, Alberts MJ. Intracerebral hemorrhage outcome:Apolipoprotein E genotype, hematoma, and edema volumes. Neurology. 1999;53:2176-2179.
10. McCarron MO, Weir CJ, Muir KW, Hoffmann KL, Graffagnino C, Nicoll JA, Lees KR, Alberts MJ. Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand. 2003;107:106-109.
11. Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG. Phenotypes of apolipoprotein b and apolipoprotein E after liver transplantation. J Clin Invest. 1991;88:270-281.
12. Laskowitz DT, Thekdi AD, Thekdi SD, Han SK, Myers JK, Pizzo SV, Bennett ER. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp Neurol. 2001;167:74-85.
13. Herz J, Beffert U. Apolipoprotein e receptors:Linking brain development and Alzheimer's disease. Nat Rev Neurosci. 2000;1:51-58.
14. Hoe HS, Harris DC, Rebeck GW. Multiple pathways of apolipoprotein E signaling in primary neurons. J Neurochem. 2005;93:145-155.
15. Aono M, Bennett ER, Kim KS, Lynch JR, Myers J, Pearlstein RD, Warner DS, Laskowitz DT. Protective effect of apolipoprotein E-mimetic peptides on n-methyl-d-aspartate excitotoxicity in primary rat neuronal-glial cell cultures. Neuroscience. 2003;116:437-445.
16. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human apoe3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem. 1997;272:17972-17980.
17. Sullivan PM, Mace BE, Maeda N, Schmechel DE. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience. 2004;124:725-733.
18. Rosenberg GA, Estrada E, Wesley M, Kyner WT. Autoradiographic patterns of brain interstitial fluid flow after collagenase-induced haemorrhage in rat. Acta Neurochir Suppl (Wien). 1990;51:280-282.
19. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The Rotorod test:An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma. 1994;11:187-196.
20. Garcia JH, Wagner S, Liu KF, Hu XJ Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627-635.
21. Zhang X, Li H, Hu S, Zhang L, Liu C, Zhu C, Liu R, Li C. Brain edema after intracerebral hemorrhage in rats:The role of inflammation. Neurol India. 2006;54:402-407.
22. Song EC, Chu K, Jeong SW, Jung KH, Kim SH, Kim M, Yoon BW. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 2003;34:2215-2220.
23. Livak KJ, Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods. 2001;25:402-408.
24. Martinez-Gonzalez NA, Sudlow CL. Effects of apolipoprotein e genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77:1329-1335.
25. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z. Apolipoprotein e-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology. 1999;52:244-248.
26. James ML, Warner DS, Laskowitz DT Preclinical models of intracerebral hemorrhage:A translational perspective. Neurocrit Care. 2007.
27. Colton CA, Czapiga M, Snell-Callanan J, Chernyshev ON, Vitek MP. Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. Biochim Biophys Acta. 2001:1535:134-144.
28. Grunenfelder J, Umbehr M, Plass A, Bestmann L, Maly FE, Zund G, Turina M. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2004;128:92-97.
29. Moretti EW, Morris RW, Podgoreanu M, Schwinn DA, Newman MF, Bennett E, Moulin VG, Mba UU, Laskowitz DT. ApoE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med. 2005;33:2521-2526.
30. Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, Strittmatter WJ, Schmechel DE, Vitek MP. ApoE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neu-roimmunol. 2004;147:62-67.
31. Hoe HS, Pocivavsek A, Chakraborty G, Fu Z, Vicini S, Ehlers MD, Rebeck GW. Apolipoprotein E receptor 2 interactions with the n-methyl-d-aspartate receptor. J Biol Chem. 2006;281:3425-3431.
32. Gao J, Wang H, Sheng H, Lynch JR, Warner DS, Durham L, Vitek MP, Laskowitz DT. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care. 2006;4:25-31.